Literature DB >> 9054599

Carcinogenicity of benzo[a]pyrene and manufactured gas plant residues in infant mice.

L V Rodriguez1, H A Dunsford, M Steinberg, K K Chaloupka, L Zhu, S Safe, J E Womack, L S Goldstein.   

Abstract

The present study determined tumorigenicity, tumor classification and DNA damage induced in infant mice by benzo[a]pyrene (B[a]P) or Manufactured Gas Plant (MGP) residues after a single exposure. Male and female B6C3F1 mice were exposed to B[a]P or MGP residue from a single environmental site (MGP-4) and males were also exposed to MGP residue composite from seven different sites (MGP-M7). At 26, 39 and 52 weeks after exposure tumorigenesis was assessed in lung, forestomach and liver. Formation and persistence of DNA adducts were quantified by 32P-postlabeling. Exposure of males to B[a]P induced liver tumors in a dose and time dependent manner. MGP induced more advanced tumors than B[a]P. Only a single liver tumor was found in MGP-4 treated females. No forestomach and few pulmonary adenomas were induced in males or females. MGP-4, MGP-M7 or B[a]P induced DNA adducts in males and females. Adducts in liver, lung and forestomach peaked on different days and decreased at different rates. At 24 h post-exposure, no significant differences in initial DNA adduct levels occurred in males and females exposed to MGP-4 or B[a]P. Lack of DNA damage (adducted DNA) did not account for non-responsiveness of lung and forestomach in B6C3F1 genders as well as in liver in females. MGP tumorigenicity could not be accounted for solely by B[a]P content nor did it reflect additivity of B[a]P and other carcinogenic polycyclic aromatic hydrocarbons (PAHs) in MGP. Synergy among MGP-PAHs, presence of unidentified carcinogens and/or promoters in MGP may account for MGP potency. The B6C3F1 infant male model is a convenient and rapid assay for assessing MGP liver tumorigenicity and potency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054599     DOI: 10.1093/carcin/18.1.127

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  5 in total

1.  Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma.

Authors:  Yu-Jing Zhang
Journal:  World J Hepatol       Date:  2010-03-27

2.  Fetal mouse Cyp1b1 and transplacental carcinogenesis from maternal exposure to dibenzo(a,l)pyrene.

Authors:  David J Castro; William M Baird; Clifford B Pereira; Jack Giovanini; Christiane V Löhr; Kay A Fischer; Zhen Yu; Frank J Gonzalez; Sharon K Krueger; David E Williams
Journal:  Cancer Prev Res (Phila)       Date:  2008-03-19

3.  Tumors and DNA adducts in mice exposed to benzo[a]pyrene and coal tars: implications for risk assessment.

Authors:  L S Goldstein; E H Weyand; S Safe; M Steinberg; S J Culp; D W Gaylor; F A Beland; L V Rodriguez
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

4.  Hepatitis B spliced protein (HBSP) promotes the carcinogenic effects of benzo [alpha] pyrene by interacting with microsomal epoxide hydrolase and enhancing its hydrolysis activity.

Authors:  Jin-Yan Chen; Wan-Nan Chen; Bo-Yan Jiao; Wan-Song Lin; Yun-Li Wu; Ling-Ling Liu; Xu Lin
Journal:  BMC Cancer       Date:  2014-04-23       Impact factor: 4.430

5.  Hazard and risk assessment of chemical mixtures using the toxic equivalency factor approach.

Authors:  S H Safe
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.